Developing a DKK1 RNAscope Biomarker Assay for DKN-01 Patient Stratification

Time: 5:45 pm
day: Track A - Day 1 pm

Details:

• Justifying the mechanistic rationale for neutralising DKK1 in oncology
• Delving into the development of a DKK1 RNAscope biomarker assay
• Sharing results from Leap Therapeutics’ DisTinGuish clinical trial

Speakers: